Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29; PMID:24399786; http://dx.doi.org/10.3322/caac.21208
   PubMed Web of Science ®Google Scholar
• Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326:455-65; PMID:1732772; http://dx.doi.org/10.1056/NEJM199202133260706
   PubMed Web of Science ®Google Scholar
• Cubilla AL, Fitzgerald PJ, Fortner JG. Pancreas cancer–duct cell adenocarcinoma: survival in relation to site, size, stage and type of therapy. J Surg Oncol 1978; 10:465-82; PMID:215845; http://dx.doi.org/10.1002/jso.2930100602
   PubMed Web of Science ®Google Scholar
• Fujino Y, Suzuki Y, Ajiki T, Tanioka Y, Ku Y, Kuroda Y. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline. Hepatogastroenterology 2003; 50:250-3; PMID:12630033
   PubMed Web of Science ®Google Scholar
• Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991; 351:233-6; PMID:2041570; http://dx.doi.org/10.1038/351233a0
   PubMed Web of Science ®Google Scholar
• Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991; 351:230-3; PMID:2041569; http://dx.doi.org/10.1038/351230a0
   PubMed Web of Science ®Google Scholar
• Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993; 268:24543-6; PMID:8227011
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993; 268:24539-42; PMID:8227010
   PubMed Web of Science ®Google Scholar
• Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 2001; 281:H2337-65; PMID:11709400
   PubMed Web of Science ®Google Scholar
• Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med 2008; 264:224-36; PMID:18793332; http://dx.doi.org/10.1111/j.1365-2796.2008.01981.x
   PubMed Web of Science ®Google Scholar
• Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95:651-7; PMID:7860748; http://dx.doi.org/10.1172/JCI117710
   PubMed Web of Science ®Google Scholar
• Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996; 93:156-60; PMID:8552595; http://dx.doi.org/10.1073/pnas.93.1.156
   PubMed Web of Science ®Google Scholar
• Lyall F, Dornan ES, McQueen J, Boswell F, Kelly M. Angiotensin II increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells via the angiotensin II AT1 receptor. J Hypertens 1992; 10:1463-9; PMID:1338078; http://dx.doi.org/10.1097/00004872-199210120-00005
   PubMed Web of Science ®Google Scholar
• Neyses L, Nouskas J, Luyken J, Fronhoffs S, Oberdorf S, Pfeifer U, Williams RS, Sukhatme VP, Vetter H. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J Hypertens 1993; 11:927-34; PMID:7504706; http://dx.doi.org/10.1097/00004872-199309000-00006
   PubMed Web of Science ®Google Scholar
• Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II–induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res 1993; 73:424-38; PMID:8348687; http://dx.doi.org/10.1161/01.RES.73.3.424
   PubMed Web of Science ®Google Scholar
• Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275:26765-71; PMID:10837481
   PubMed Web of Science ®Google Scholar
• Fujiyama S, Matsubara H, Nozawa Y, Maruyama K, Mori Y, Tsutsumi Y, Masaki H, Uchiyama Y, Koyama Y, Nose A, et al. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 2001; 88:22-9; PMID:11139469; http://dx.doi.org/10.1161/01.RES.88.1.22
   PubMed Web of Science ®Google Scholar
• Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985; 105:141-5; PMID:2579174
   PubMed Web of Science ®Google Scholar
• le Noble FA, Kessels-van Wylick LC, Hacking WJ, Slaaf DW, oude Egbrink MG, Struijker-Boudier HA. The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network. J Vasc Res 1996; 33:480-8; PMID:8998197
   PubMed Web of Science ®Google Scholar
• Johnstone MT, Perez AS, Nasser I, Stewart R, Vaidya A, Al Ammary F, Schmidt B, Horowitz G, Dolgoff J, Hamilton J, et al. Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model. Circulation 2004; 110:2060-5; PMID:15451796; http://dx.doi.org/10.1161/01.CIR.0000143627.55926.4C
   PubMed Web of Science ®Google Scholar
• Lee FT, Cao Z, Long DM, Panagiotopoulos S, Jerums G, Cooper ME, Forbes JM. Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J Am Soc Nephrol 2004; 15:2139-51; PMID:15284299; http://dx.doi.org/10.1097/01.ASN.0000135055.61833.A8
   PubMed Web of Science ®Google Scholar
• Ino K, Shibata K, Kajiyama H, Yamamoto E, Nagasaka T, Nawa A, Nomura S, Kikkawa F. Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. Br J Cancer 2006; 94:552-60; PMID:16434990; http://dx.doi.org/10.1038/sj.bjc.6602961
   PubMed Web of Science ®Google Scholar
• Rocken C, Rohl FW, Diebler E, Lendeckel U, Pross M, Carl-McGrath S, Ebert MP. The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:1206-12; PMID:17548686; http://dx.doi.org/10.1158/1055-9965.EPI-05-0934
   PubMed Web of Science ®Google Scholar
• Arrieta O, Pineda-Olvera B, Guevara-Salazar P, Hernandez-Pedro N, Morales-Espinosa D, Ceron-Lizarraga TL, González-De la Rosa CH, Rembao D, Segura-Pacheco B, Sotelo J. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. Br J Cancer 2008; 99:160-6; PMID:18594540; http://dx.doi.org/10.1038/sj.bjc.6604431
   PubMed Web of Science ®Google Scholar
• Shirotake S, Miyajima A, Kosaka T, Tanaka N, Maeda T, Kikuchi E, Oya M. Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer. Urology 2011; 77:1009.e19-25; PMID:21296393; http://dx.doi.org/10.1016/j.urology.2010.11.002
   PubMedGoogle Scholar
• Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003; 112:67-75; PMID:12840060; http://dx.doi.org/10.1172/JCI16645
   PubMed Web of Science ®Google Scholar
• Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005; 26:271-9; PMID:15637093; http://dx.doi.org/10.1093/carcin/bgh324
   PubMed Web of Science ®Google Scholar
• Miyajima A, Kosaka T, Asano T, Asano T, Seta K, Kawai T, Hayakawa M. Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis. Cancer Res 2002; 62:4176-9; PMID:12154013
   PubMed Web of Science ®Google Scholar
• Miura S, Karnik SS. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. Embo J 2000; 19:4026-35; PMID:10921883; http://dx.doi.org/10.1093/emboj/19.15.4026
   PubMed Web of Science ®Google Scholar
• Doi C, Egashira N, Kawabata A, Maurya DK, Ohta N, Uppalapati D, Ayuzawa R, Pickel L, Isayama Y, Troyer D, et al. Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice. BMC Cancer 2010; 10:67; PMID:20181281; http://dx.doi.org/10.1186/1471-2407-10-67
   PubMed Web of Science ®Google Scholar
• Magnani F, Pappas CG, Crook T, Magafa V, Cordopatis P, Ishiguro S, Ohta N, Selent J, Bosnyak S, Jones ES, et al. Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II. ACS Chem Biol 2014; 9:1420-5; PMID:24787922; http://dx.doi.org/10.1021/cb500063y
   PubMed Web of Science ®Google Scholar
• Chappell MC, Diz DI, Jacobsen DW. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides 1992; 13:313-8; PMID:1409010; http://dx.doi.org/10.1016/0196-9781(92)90114-I
   PubMed Web of Science ®Google Scholar
• Leung PS, Chan HC, Fu LX, Wong PY. Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents. J Endocrinol 1997; 153:269-74; PMID:9166116; http://dx.doi.org/10.1677/joe.0.1530269
   PubMed Web of Science ®Google Scholar
• Leung PS, Chan WP, Wong TP, Sernia C. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 1999; 160:13-9; PMID:9854172; http://dx.doi.org/10.1677/joe.0.1600013
   PubMed Web of Science ®Google Scholar
• Lam KY, Leung PS. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur J Endocrinol 2002; 146:567-72; PMID:11916627; http://dx.doi.org/10.1530/eje.0.1460567
   PubMed Web of Science ®Google Scholar
• Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292:C82-97; PMID:16870827; http://dx.doi.org/10.1152/ajpcell.00287.2006
   PubMed Web of Science ®Google Scholar
• Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008; 120:292-316; PMID:18804122; http://dx.doi.org/10.1016/j.pharmthera.2008.08.009
   PubMed Web of Science ®Google Scholar
• Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest Surg 2008; 12:57-66; PMID:18026817; http://dx.doi.org/10.1007/s11605-007-0403-9
   PubMed Web of Science ®Google Scholar
• Nakai Y, Isayama H, Ijichi H, Sasaki T, Sasahira N, Hirano K, Kogure H, Kawakubo K, Yagioka H, Yashima Y, et al. Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer 2010; 103:1644-8; PMID:20978506; http://dx.doi.org/10.1038/sj.bjc.6605955
   PubMed Web of Science ®Google Scholar
• Fujimoto Y, Sasaki T, Tsuchida A, Chayama K. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 2001; 495:197-200; PMID:11334891; http://dx.doi.org/10.1016/S0014-5793(01)02377-8
   PubMed Web of Science ®Google Scholar
• McGhee A, Sivarajah M, Gong Q, Lim S, Chipitsyna G, Yeo CJ, Arafat HA. Angiotensin II type 2 receptor blockade inhibits fatty acid synthase production through activation of AMP-activated protein kinase in pancreatic cancer cells. Surgery 2011; 150:284-98; PMID:21801966; http://dx.doi.org/10.1016/j.surg.2011.06.002
   PubMed Web of Science ®Google Scholar
• Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price E, Jr., Roberts RL, Imboden H, Fitzgerald TG, Gaffney FA, Inagami T. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. Embo J 2003; 22:6471-82; PMID:14657020; http://dx.doi.org/10.1093/emboj/cdg637
   PubMed Web of Science ®Google Scholar
• Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296:1655-7; PMID:12040186; http://dx.doi.org/10.1126/science.296.5573.1655
   PubMed Web of Science ®Google Scholar
• Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205-51; PMID:8372104
   PubMed Web of Science ®Google Scholar
• Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. J Am Coll Surg 2007; 204:996-1005; discussion -6; PMID:17481528; http://dx.doi.org/10.1016/j.jamcollsurg.2007.01.067
   PubMed Web of Science ®Google Scholar
• Miura S, Karnik SS, Saku K. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J Biol Chem 2005; 280:18237-44; PMID:15746093; http://dx.doi.org/10.1074/jbc.M500639200
   PubMed Web of Science ®Google Scholar
• Tamura M, Wanaka Y, Landon EJ, Inagami T. Intracellular sodium modulates the expression of angiotensin II subtype 2 receptor in PC12W cells. Hypertension 1999; 33:626-32; PMID:10024318; http://dx.doi.org/10.1161/01.HYP.33.2.626
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Ann N York Acad Sci 1949; 51:660-72; http://dx.doi.org/10.1111/j.1749-6632.1949.tb27297.x
   Web of Science ®Google Scholar
• Puolakkainen PA, Brekken RA, Muneer S, Sage EH. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol Cancer Res 2004; 2:215-24; PMID:15140943
   PubMed Web of Science ®Google Scholar
• Teicher BA. Tumor Models in Cancer Research. New York, Humana Press, 2002.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Matsuzuka T, Rachakatla RS, Doi C, Maurya DK, Ohta N, Kawabata A, Pyle MM, Pickel L, Reischman J, Marini F, et al. Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice. Lung Cancer 2010; 70:28-36; PMID:20138387; http://dx.doi.org/10.1016/j.lungcan.2010.01.003
   PubMed Web of Science ®Google Scholar